Andrew Hill Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Andrew Hill Investment Advisors's ABBV Position: Q3 2022 in Review
Andrew Hill Investment Advisors reduced its AbbVie (ABBV) stake by 25% in Q3 2022, selling an estimated $1.02M and leaving 21,806 shares worth $2.93M. The position accounts for 3.97% of the portfolio, ranked #12.
Andrew Hill Investment Advisors first reported a position in ABBV in Q4 2021 and has held it in 4 quarters since. The position peaked at $5.44M in Q1 2022. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.
- Andrew Hill Investment Advisors held 21,806 shares of AbbVie worth $2.93M as of Q3 2022.
- Andrew Hill Investment Advisors sold 7,111 AbbVie shares in Q3 2022, an estimated $1.02M.
- AbbVie made up 3.97% of Andrew Hill Investment Advisors's portfolio in Q3 2022, its #12 holding.
- Andrew Hill Investment Advisors first reported a position in AbbVie in Q4 2021 and has held it in 4 quarters since.
- Andrew Hill Investment Advisors's AbbVie position peaked at $5.44M in Q1 2022.
- 2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.
Based on Andrew Hill Investment Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.